Preclinical Bioanalytical Testing Services Market, By Workflow (Sample Analysis, Method Development and Validation, and Sample Collection and Preparation), By Molecule, By Test, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4567
|
Published Date
December 2025
|
Pages
355
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Preclinical Bioanalytical Testing Services Market size was valued at US$ 1,234.56 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
The Preclinical Bioanalytical Testing Services Market is a specialized segment of contract research and laboratory services that supports drug development by evaluating pharmacokinetics (PK), toxicology, biomarkers, and bioavailability of drug candidates before clinical trials. These services provide accurate, compliant, and data-driven assessments of a molecule’s safety and efficacy. Market growth is driven by the rising development of biologics and complex therapeutic modalities that require advanced analytical platforms. Key trends include increased adoption of high-sensitivity LC-MS/MS techniques and automation to enhance throughput, precision, and data reliability. However, the market faces challenges such as high operational costs and stringent regulatory requirements, which can extend testing timelines. Despite these hurdles, growing outsourcing by pharmaceutical and biotechnology companies—particularly for specialized assays and method development—presents significant opportunities, positioning preclinical bioanalytical services as a critical component of modern drug discovery.
Preclinical Bioanalytical Testing Services Market- Market Dynamics
Rising Prevalence of Chronic Diseases Drives Market Growth
The increasing prevalence of chronic diseases is a key factor driving growth in the preclinical bioanalytical testing services market. Chronic diseases—long-lasting conditions such as cardiovascular disorders, diabetes, and cancer—require continuous monitoring and effective therapeutic management. Preclinical bioanalytical testing services play a crucial role by analyzing drug candidates for pharmacokinetics, toxicology, and biomarkers, helping ensure safety and efficacy before clinical trials. These services also support therapeutic drug monitoring, enabling precise measurement of drug levels and biomarker responses, which is particularly important for developing treatments for chronic conditions.
According to the U.S. National Library of Medicine, the population aged 50 and older with at least one chronic condition in the United States is projected to nearly double to 142.66 million by 2050. Globally, the World Health Organization (WHO) reported that noncommunicable diseases (NCDs) accounted for 41 million deaths in 2022, representing 74% of all deaths worldwide. This rising burden of chronic illnesses is creating greater demand for advanced bioanalytical testing solutions, positioning the preclinical bioanalytical testing services market as a critical component in modern drug development pipelines.
Preclinical Bioanalytical Testing Services Market- Segmentation Analysis:
The Global Preclinical Bioanalytical Testing Services Market is segmented by Workflow, Molecule, Test, End Use and Region.
According to the test, the bioavailability test segment is expected to hold the most significant share in the bioanalytical testing services market. Bioavailability testing is essential for evaluating the pharmacokinetic profile and therapeutic efficacy of new drug formulations during clinical trials. The rising number of active clinical trials globally has further increased the demand for bioavailability assessments, ensuring consistency and stability across drug formulations and improving patient outcomes. Government and regulatory data support this trend; for example, the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) reported that clinical trial registrations in the Western Pacific region rose sharply in 2022, with China and Japan leading the region in new trial initiations. These statistics underscore the growing reliance on bioanalytical testing to support regulatory compliance and safe, effective drug development.
By workflow, the sample collection and preparation segment dominates the market due to its selectivity, convenience, speed, and flexibility in extraction phase configurations. Advances in technology have led to the development of automated and miniaturized sample preparation methods, reducing solvent usage and supporting on-site, in situ, and in vivo applications. Government and regulatory initiatives further highlight the importance of standardized laboratory practices; for instance, the U.S. Food and Drug Administration (FDA) reported that over 65% of IVD-certified laboratories implemented automated sample preparation solutions in 2023 to ensure accuracy and reproducibility in diagnostics. In November 2023, Thermo Fisher Scientific introduced new automated sample preparation solutions for laboratories certified for in vitro diagnostics (IVD) and IVD regulation (IVD-R), enhancing efficiency and reliability in respiratory diagnostic testing and demonstrating the market’s shift toward automation and advanced workflow solutions.
Preclinical Bioanalytical Testing Services Market- Geographical Insights
North America is a key market for preclinical bioanalytical testing services, driven by its strong pharmaceutical and biotechnology sectors, advanced infrastructure, and focus on innovation. The United States, in particular, exhibits high demand for bioanalytical testing due to its large pipeline of drug candidates and strict FDA regulatory requirements, which mandate rigorous testing and validation. Major companies are expanding their service offerings to meet this growing demand. For example, in August 2024, SGS Société Générale de Surveillance SA launched new bioanalytical testing services in North America in partnership with Agilex Biolabs Pty Ltd., enhancing the region’s testing capabilities and supporting clinical trials and drug development.
United States Preclinical Bioanalytical Testing Services Market – Country Insights
The U.S. market is witnessing rapid growth, fueled by the rising demand for precision medicine and the increasing development of biologics and biosimilars. As of December 2024, the United States had 64 approved biosimilars, reflecting its leadership in biologics innovation and the resulting need for bioanalytical validation. The growing emphasis on pharmacokinetic (PK) and pharmacodynamic (PD) studies has further increased demand for specialized analytical services. Additionally, substantial funding for life sciences research, combined with strict regulatory oversight, has encouraged pharmaceutical companies to outsource bioanalytical testing to ensure consistent and reliable data. The adoption of advanced technologies such as high-throughput screening and LC-MS/MS enhances testing accuracy, efficiency, and turnaround times, reinforcing the region’s dominance in the preclinical bioanalytical testing services market.
Preclinical Bioanalytical Testing Services Market- Competitive Landscape:
The preclinical bioanalytical testing services market is highly competitive and fragmented, comprising both established players and emerging startups. Companies are focusing on strategic collaborations, mergers and acquisitions, and technological innovation to strengthen their market positions and expand their geographic reach. The rising demand for specialized bioanalytical services, driven by advancements in pharmaceutical and biotechnology research, has intensified competition. In this environment, quality, reliability, and regulatory compliance are key differentiators. Leading players in the market include Thermo Fisher Scientific Inc. (including PPD, Inc.), Parexel International, Pharmaron, and BioAgilytix Labs, all of which provide a comprehensive range of bioanalytical services to pharmaceutical and biotechnology clients worldwide.
Recent Developments:
- In June 2024, Pace Analytical Services acquired Curia’s laboratory facility in Lebanon, New Jersey. This acquisition enhances Pace’s ability to support emerging biopharma companies by offering rapid, expert analytical and development services on a commercial scale.
- In November 2024, Altasciences expanded its bioanalytical service portfolio, providing flexible, high-quality analytical solutions for both preclinical and clinical studies. This expansion reinforces the company’s long-standing commitment to accelerating global drug development and supporting client success.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Charles River Laboratories International
- Syneos Health
- SGS SA
- WuXi AppTec
- Thermo Fisher Scientific Inc (PPD, Inc.)
- Parexel International
- Pharmaron
- BioAgilytix Labs
- KCAS Bio
- ICON plc
- Labcorp
- Eurofins Scientific SE
- QPS Holdings
- Altasciences
- Others
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032
- Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Spectroscopic Techniques
- Genomic and Molecular Techniques
- Method Development and Validation
- Sample Collection and Preparation
- Sample Collection, Handling and Storage
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
- Others
- Other processes
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032
- Small Molecule
- Large Molecule
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Bioavailability
- Bioequivalence
- Biomarker Testing
- ADME
- In-vivo
- In-vitro
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Cell-based Assay
- Virology Testing
- Other Tests
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- CDMO
- CRO
- Pharma & BioPharma Companies
- Others
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Preclinical Bioanalytical Testing Services Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Preclinical Bioanalytical Testing Services Market Snippet by Workflow
2.1.2. Preclinical Bioanalytical Testing Services Market Snippet by Molecule
2.1.3. Preclinical Bioanalytical Testing Services Market Snippet by Test
2.1.4. Preclinical Bioanalytical Testing Services Market Snippet by End Use
2.1.5. Preclinical Bioanalytical Testing Services Market Snippet by Country
2.1.6. Preclinical Bioanalytical Testing Services Market Snippet by Region
2.2. Competitive Insights
3. Preclinical Bioanalytical Testing Services Key Market Trends
3.1. Preclinical Bioanalytical Testing Services Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Preclinical Bioanalytical Testing Services Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Preclinical Bioanalytical Testing Services Market Opportunities
3.4. Preclinical Bioanalytical Testing Services Market Future Trends
4. Preclinical Bioanalytical Testing Services Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Preclinical Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Preclinical Bioanalytical Testing Services Market Landscape
6.1. Preclinical Bioanalytical Testing Services Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Preclinical Bioanalytical Testing Services Market – By Workflow
7.1. Overview
7.1.1. Segment Share Analysis, By Workflow, 2024 & 2032 (%)
7.1.2. Sample Analysis
7.1.2.1. Hyphenated technique
7.1.2.2. Chromatographic technique
7.1.2.3. Electrophoresis
7.1.2.4. Ligand Binding Assay
7.1.2.5. Mass Spectrometry
7.1.2.6. Spectroscopic Techniques
7.1.2.7. Genomic and Molecular Techniques
7.1.3. Method Development and Validation
7.1.4. Sample Collection and Preparation
7.1.4.1. Sample Collection, Handling and Storage
7.1.4.2. Protein Precipitation
7.1.4.3. Liquid-Liquid Extraction
7.1.4.4. Solid Phase Extraction
7.1.4.5. Others
7.1.5. Other processes
8. Preclinical Bioanalytical Testing Services Market – By Molecule
8.1. Overview
8.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
8.1.2. Small Molecule
8.1.3. Large Molecule
9. Preclinical Bioanalytical Testing Services Market – By Test
9.1. Overview
9.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
9.1.2. Bioavailability
9.1.3. Bioequivalence
9.1.4. Biomarker Testing
9.1.5. ADME
9.1.5.1. In-vivo
9.1.5.2. In-vitro
9.1.6. Pharmacokinetics (PK)
9.1.7. Pharmacodynamics (PD)
9.1.8. Cell-based Assay
9.1.9. Virology Testing
9.1.10. Other Tests
10. Preclinical Bioanalytical Testing Services Market – By End Use
10.1. Overview
10.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
10.1.2. CDMO
10.1.3. CRO
10.1.4. Pharma & BioPharma Companies
10.1.5. Others
11. Preclinical Bioanalytical Testing Services Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Preclinical Bioanalytical Testing Services Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Preclinical Bioanalytical Testing Services Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Charles River Laboratories International
12.2.2. Syneos Health
12.2.3. SGS SA
12.2.4. WuXi AppTec
12.2.5. Thermo Fisher Scientific Inc (PPD, Inc.)
12.2.6. Parexel International
12.2.7. Pharmaron
12.2.8. BioAgilytix Labs
12.2.9. KCAS Bio
12.2.10. ICON plc
12.2.11. Labcorp
12.2.12. Eurofins Scientific SE
12.2.13. QPS Holdings
12.2.14. Altasciences
12.2.15. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Charles River Laboratories International
- Syneos Health
- SGS SA
- WuXi AppTec
- Thermo Fisher Scientific Inc (PPD, Inc.)
- Parexel International
- Pharmaron
- BioAgilytix Labs
- KCAS Bio
- ICON plc
- Labcorp
- Eurofins Scientific SE
- QPS Holdings
- Altasciences
- Others
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032
- Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Spectroscopic Techniques
- Genomic and Molecular Techniques
- Method Development and Validation
- Sample Collection and Preparation
- Sample Collection, Handling and Storage
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
- Others
- Other processes
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032
- Small Molecule
- Large Molecule
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Bioavailability
- Bioequivalence
- Biomarker Testing
- ADME
- In-vivo
- In-vitro
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Cell-based Assay
- Virology Testing
- Other Tests
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- CDMO
- CRO
- Pharma & BioPharma Companies
- Others
GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
